NEW YORK (GenomeWeb) – With the reissuance late last year of its Clinical Proteomic Tumor Analysis Consortium program, the National Cancer Institute looks to build on the achievements of the initiative's previous two stages while moving the work in an increasingly translational direction.

NCI announced in November that it was soliciting applications for the next stage of the CPTAC project, offering funding for three Proteome Characterization Centers (PCCs), four Proteogenomic Data Analysis Centers (PDACs), and three Proteogenomics Translational Research Centers (PTRCs).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.